Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial.
Sagara I, Rulisa S, Mbacham W, Adam I, Sissoko K, Maiga H, Traore OB, Dara N, Dicko YT, Dicko A, Djimdé A, Jansen FH, Doumbo OK. Sagara I, et al. Among authors: mbacham w. Malar J. 2009 Apr 14;8:63. doi: 10.1186/1475-2875-8-63. Malar J. 2009. PMID: 19366448 Free PMC article. Clinical Trial.
The importance and future of malaria research in Africa.
Ntoumi F, Djimde AA, Mbacham W, Egwang T. Ntoumi F, et al. Among authors: mbacham w. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):IV. Am J Trop Med Hyg. 2004. PMID: 15331851 No abstract available.
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Mbacham WF, Evehe MS, Netongo PM, Ateh IA, Mimche PN, Ajua A, Nji AM, Irenee D, Echouffo-Tcheugui JB, Tawe B, Hallett R, Roper C, Targett G, Greenwood B. Mbacham WF, et al. Malar J. 2010 Jan 27;9:34. doi: 10.1186/1475-2875-9-34. Malar J. 2010. PMID: 20105282 Free PMC article. Clinical Trial.
Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites.
Diakite M, Achidi EA, Achonduh O, Craik R, Djimde AA, Evehe MS, Green A, Hubbart C, Ibrahim M, Jeffreys A, Khan BK, Kimani F, Kwiatkowski DP, Mbacham WF, Jezan SO, Ouedraogo JB, Rockett K, Rowlands K, Tagelsir N, Tekete MM, Zongo I, Ranford-Cartwright LC. Diakite M, et al. Malar J. 2011 Aug 25;10:250. doi: 10.1186/1475-2875-10-250. Malar J. 2011. PMID: 21867552 Free PMC article.
Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes.
Ali IM, Netongo PM, Atogho-Tiedeu B, Ngongang EO, Ajua A, Achidi EA, Mbacham WF. Ali IM, et al. Malar Res Treat. 2013;2013:234683. doi: 10.1155/2013/234683. Epub 2013 Dec 15. Malar Res Treat. 2013. Retraction in: Malar Res Treat. 2019 Jun 20;2019:4274315. doi: 10.1155/2019/4274315 PMID: 24455414 Free PMC article. Retracted.
Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Nji AM, Ali IM, Moyeh MN, Ngongang EO, Ekollo AM, Chedjou JP, Ndikum VN, Evehe MS, Froeschl G, Heumann C, Mansmann U, Ogundahunsi O, Mbacham WF. Nji AM, et al. Malar J. 2015 Jan 28;14:27. doi: 10.1186/s12936-014-0521-2. Malar J. 2015. PMID: 25626448 Free PMC article. Clinical Trial.
130 results